| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/28/1994 | WO1994008616A1 Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide |
| 04/28/1994 | WO1994008615A1 Antibody to naturally-occurring aminomalonic acid and uses therefor |
| 04/28/1994 | WO1994008614A1 Recombinant alliinase, its preparation and pharmaceutical compositions comprising it |
| 04/28/1994 | WO1994008613A2 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy |
| 04/28/1994 | WO1994008611A1 GROWTH HORMONE FRAGMENT hGH 108-129 |
| 04/28/1994 | WO1994008610A1 Pharmaceutical emulsion compositions |
| 04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
| 04/28/1994 | WO1994008608A1 Amino acid conjugates of cyclohexapeptidyl amines |
| 04/28/1994 | WO1994008607A1 Novel pseudopeptide bradykinin receptor antagonists |
| 04/28/1994 | WO1994008606A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
| 04/28/1994 | WO1994008605A1 Therapeutic microemulsions |
| 04/28/1994 | WO1994008604A1 Convertible microemulsion formulations |
| 04/28/1994 | WO1994008603A1 Compositions |
| 04/28/1994 | WO1994008602A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
| 04/28/1994 | WO1994008600A1 Inhibition of signal transduction molecules |
| 04/28/1994 | WO1994008599A1 Ion-pairing of drugs for improved efficacy and delivery |
| 04/28/1994 | WO1994008548A1 Transfusion liquid-containing holder and prepared transfusion liquid |
| 04/28/1994 | WO1994008454A1 Methods, compositions and screening assays relating to autoimmune disease |
| 04/28/1994 | WO1994005296A3 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 04/28/1994 | WO1993024640A3 Methods and compositions for in vivo gene therapy |
| 04/28/1994 | DE4244738A1 Use of C1-inactivator - to combat complications e.g. generalised oedema and refractory hypotension resulting from bone marrow transplants. |
| 04/28/1994 | DE4244737A1 Use of C1 inactivator - to control complications such as generalised oedema and refractory hypotension resulting from multiple trauma |
| 04/28/1994 | DE4244736A1 Use of C1-inactivator - to combat complications such as generalised oedema and refractory hypotension during operations involving extracorporeal circulation. |
| 04/28/1994 | DE4244715A1 Isolation of circulating cancer cells from bloodstream |
| 04/28/1994 | DE4236069A1 Homeopathic medicaments for treating HIV infections - prepd. by dilution of infected serum |
| 04/28/1994 | DE4228457A1 Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen Production of heterodimeric PDGF-AB using a bicistronic vector system in mammalian cells |
| 04/28/1994 | CA2147599A1 Container filled with infusion liquids and infusion preparation |
| 04/28/1994 | CA2147466A1 Interleukin-6 receptor antagonists |
| 04/28/1994 | CA2147180A1 Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
| 04/28/1994 | CA2147167A1 A new class of rptpases: their structural domains and ligands |
| 04/28/1994 | CA2147127A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | CA2147010A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies |
| 04/28/1994 | CA2146929A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | CA2146869A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/28/1994 | CA2146862A1 The taga gene and methods for detecting predisposition to peptic ulceration |
| 04/28/1994 | CA2146855A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | CA2146854A1 Recombinant specific binding protein |
| 04/28/1994 | CA2146766A1 Polypeptides with a serotoninergic receptor activity (5ht2c) and uses therefor |
| 04/28/1994 | CA2146666A1 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy |
| 04/28/1994 | CA2146446A1 Arginine keto-amide enzyme inhibitors |
| 04/28/1994 | CA2145863A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
| 04/28/1994 | CA2145203A1 Amino acid conjugates of cyclohexapeptidyl amines |
| 04/28/1994 | CA2144738A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
| 04/28/1994 | CA2126093A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
| 04/28/1994 | CA2125784A1 Injectable lecithin gel |
| 04/27/1994 | EP0594540A1 Antiretroviral acyl compounds |
| 04/27/1994 | EP0594492A2 Growth inhibitory factor |
| 04/27/1994 | EP0594311A1 Metastasis-inhibiting protein, and DNA encoding said protein |
| 04/27/1994 | EP0594284A2 Antibody containing pharmaceutical composition against aids |
| 04/27/1994 | EP0594235A2 Method of purification of amylase, purified amylase so obtained and uses of purified amylase |
| 04/27/1994 | EP0593868A1 PEG-interferon conjugates |
| 04/27/1994 | EP0593857A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 04/27/1994 | EP0593794A1 Isolated mink growth hormone genes, novel recombinant DNA and methods for producing mink growth hormone |
| 04/27/1994 | EP0593755A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 04/27/1994 | EP0593754A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 04/27/1994 | EP0593663A1 Method and assay system for neurotrophin activity |
| 04/27/1994 | EP0593658A1 Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
| 04/27/1994 | EP0593639A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same. |
| 04/27/1994 | EP0593620A1 Herpes virus proteinase and method of assaying |
| 04/27/1994 | EP0593585A1 Peptide which abrogates tnf and/or lps toxicity |
| 04/27/1994 | EP0593559A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 04/27/1994 | EP0593516A1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 04/27/1994 | EP0593501A1 Biocidal proteins |
| 04/27/1994 | EP0514442B1 N-phenyl n-acetamido glycinamides, preparation method and drugs containing them |
| 04/27/1994 | EP0462145B1 Covalent conjugates of lipid and oligonucleotide |
| 04/27/1994 | EP0455725B1 Pharmaceutical formulations of plasminogen activator proteins |
| 04/27/1994 | CN1085913A Glucagon-like peptide and insulinotropin derivatives |
| 04/27/1994 | CN1085912A Peptide compounds |
| 04/27/1994 | CN1085911A Peptide compounds |
| 04/27/1994 | CN1085805A Vaccine compositions |
| 04/27/1994 | CN1085804A Stabilized somatotropin for parenterai administration |
| 04/27/1994 | CN1085803A Medicine for improving growth of liver cell and its method for production |
| 04/27/1994 | CN1085802A Treatment of hepatitis with GM-CSF |
| 04/26/1994 | US5306812 Has capability of binding to heavy chain variable regions of antibodies in an antigen independent manner and can separate antigen/antibody complexes |
| 04/26/1994 | US5306808 Endothelin derivatives |
| 04/26/1994 | US5306710 Method for treating endotoxin shock with CRF |
| 04/26/1994 | US5306709 Reducing number of circulating platelets in bloodstream |
| 04/26/1994 | US5306708 Antibiotic agent |
| 04/26/1994 | US5306639 DNA encoding glucanase enzymes |
| 04/26/1994 | US5306631 Compositions and method for inhibition of HIV production |
| 04/26/1994 | US5306627 Genetic engineering |
| 04/26/1994 | US5306620 Antibodies that bind to a ligand-induced binding site on integrin and induce integrin activation |
| 04/26/1994 | US5306614 Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2) |
| 04/26/1994 | US5306508 Red blood cell surrogate |
| 04/26/1994 | US5306503 Patch with a high content of softening ingredients |
| 04/26/1994 | US5306482 Benz(alk or eth)orium chloride |
| 04/26/1994 | CA1328949C Peptide and anti-dementia agent |
| 04/26/1994 | CA1328948C Polypeptide compounds |
| 04/26/1994 | CA1328840C Fibroblast growth factor antagonists |
| 04/26/1994 | CA1328820C Amino acid compositions to inhibit adhesion of disease-causing microorganisms to teeth using such compositions |
| 04/26/1994 | CA1328808C Active agent and pharmaceutical composition containing such, for preventing and controlling human transplant rejection |
| 04/24/1994 | CA2108934A1 Antiretroviral acyl compounds |
| 04/21/1994 | DE4234921A1 Neues, die Gerinnungszeit des Blutes verlängerndes Protein aus dem Landblutegel Haemadipsa sylestris New, the clotting time of the blood elongating protein from the terrestrial leech Haemadipsa sylestris |
| 04/21/1994 | DE4234537A1 A compound a polymeric bile acid and insulin - useful in the prodn. of a medicament for diabetes mellitus, for nasal admin. |
| 04/20/1994 | EP0593339A1 Process preparation of hepatitis A antigen and vaccine |
| 04/20/1994 | EP0593176A2 Pharmaceutical compositions containing botulinum toxin and method of preparation |
| 04/20/1994 | EP0593098A2 Process and device for selective removing of photodynamic substances from blood or bloodproducts |
| 04/20/1994 | EP0593094A2 Pulmonary surfactant protein and related polypeptide |
| 04/20/1994 | EP0593092A1 Nucleic acid encoding a T-cell antigen receptor protein |
| 04/20/1994 | EP0593065A1 Recombinant fibroblast growth factors |